Stimulation of Pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells

Cell Structure and Function

Volumn 28, Issue 6, 2003, Pages 505-513

  Wang, Da Ren ^a   Sato, Mitsuru ^a   Li, Li Na ^a   Miura, Mitsutaka ^a   Kojima, Naosuke ^a   Senoo, Haruki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Extracellular matrix; Gelatin zymography; Hepatic stellate cell; MMP 2; MT1 MMP; Type I collagen

Indexed keywords

BETA1 INTEGRIN; BLOCKING ANTIBODY; COLLAGEN FIBRIL; COLLAGEN GEL; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGENASE 3; GELATIN; GELATINASE A; MATRIGEL; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROTEIN SUBUNIT; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME REPRESSION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; ZYMOGRAPHY;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE IV; CONNECTIVE TISSUE CELLS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATIN; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALE; METALLOENDOPEPTIDASES; RATS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 1942504723     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.28.505     Document Type: Article

References (59)

1. Ankoma-Sey, V., Matli, M., Chang, K.B., Lalazar, A., Donner, D.B., Wong, L., Warren, R.S., and Friedman, S.L. 1998. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene, 17: 115-121.
2. Azzam, H.S. and Thompson, E.W. 1992. Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res., 52: 4540-4544.
3. Berry, M.N. and Friend, D.S. 1969. High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study. J. Cell Biol., 43: 506-520.
4. Birk de Silver, F.H. and Trelstad, R.L. 1991. Matrix assembly. In Cell Biology of Extracellular Matrix (E.D. Hay, ed.), Plenum Press, New York, 1991, pp. 221-254.
5. Bissell, M.J., Hall, H.G., and Parry, G. 1982. How does the extracellular matrix direct gene expression? J. Theor. Biol., 99: 31-68.
6. Boyd, R.S. and Balkwill, F.R. 1999. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer, 80: 315-321.
7. Butler, G.S., Butler, M.J., Atkinson, S.J., Will, H., Tamura, T., van Westrum, S.S., Crabbe, T., Clements, J., d'Ortho, M.P., and Murphy, G. 1998. The TIMP2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem., 273: 871-880.
8. Carloni, V., Romanelli, R.G., Pinzani, M., Laffi, G., and Gentilini, P. 1996. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology, 110: 1127-1136.
9. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159.
10. Ellenrieder, V., Alber, B., Lacher, U., Hendler, S.F., Menke, A., Boeck, W., Wagner, M., Wilda, M., Friess, H., Buchler, M., Adler, G., and Gress, T.M. 2000. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer, 85: 14-20.
11. Ellerbroek, S.M., Fishman, D.A., Kearns, A.S., Bafetti, L.M., and Stack, M.S. 1999. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta 1 integrin. Cancer Res., 59: 1635-1641.
12. Freije, J.M., Diez-Itza, I., Balbin, M., Sánchez, L.M., Blasco, R., Tolivia, J., and López-Otin, C. 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem., 269: 16766-16773.
13. Friedman, A.S.L. and Arthur, J.P. 2002. Reversing hepatic fibrosis. Sci. Med., 8: 194-205.
14. Geisler, S., Lichtinghagen, R., Boker, K.H., and Veh, R.W. 1997. Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin. Cell Tissue Res., 289: 173-183.
15. Gilles, C., Polette, M., Piette, J., Munaut, C., Thompson, E.W., Birembaut, P., and Foidart, J.M. 1996. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer, 65: 209-213.
16. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E.W. 1997. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest., 76: 651-660.
17. Grab, B., Miles, A.J., Furcht, L.T., and Fields, G.B. 1996. Promotion of fibroblast adhesion by triple-helical peptide models of type I collagen-derived sequences. J. Biol. Chem., 271: 12234-12240.
18. Herbst, H., Wege, T., Milani, S., Pellegrini, G., Orzechowski, H.D., Bechstein, W.O., Neuhaus, P., Gressner, A.M., and Schuppan, D. 1997. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am. J. Pathol., 150: 1647-1659.
19. Hotary, K., Allen, E., Punturieri, A., Yana, I., and Weiss, S.J. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell. Biol., 149: 1309-1323.
20. Iredale, J.P., Murphy, G., Hembry, R.M., Friedman, S.L., and Arthur, M.J. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J. Clin. Invest., 90: 282-287.
21. Jones, P.L., Schmidhauser, C., and Bissell, M.J. 1993. Regulation of gene expression and cell function by extracellular matrix. Crit. Rev. Eukar. Gene Exp., 3: 137-141.
22. Kähäri, V.M. and Saarialho-Kere, U. 1999. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med., 31: 34-45.
23. Knäuper, V., Bailey, L., Worley, J.R., Soloway, P., Patterson, M.L., and Murphy, G. 2002. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett., 532: 127-130.
24. Knäuper, V., Will, H., Lopez-Otin, C., Smith, B., Atkinson, S.J., Stanton, H., Hembry, R.M., and Murphy, G. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem., 271: 17124-17131.
25. Knittel, T., Mehde, M., Kobold, D., Saile, B., Dinter, C., and Ramadori, G. 1999. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β 1. J. Hepatol., 30: 48-60.
26. Kojima, N., Sato, M., Imai, K., Miura, M., Marano, Y., and Senoo, H. 1998. Hepatic stellate cells (vitamin A-storing cells) change their cytoskeleton structure by extracellular matrix components through a signal transduction system. Histochem. Cell Biol., 110: 121-128.
27. Koyama, H., Raines, E.W., Bornfeldt, K.E., Roberts, J.M., and Ross, R. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell., 87: 1069-1078.
28. Kurschat, P., Zigrino, P., Nischt, R., Breitkopf, K., Steurer, P., Klein, C.E., Krieg, T., and Mauch, C. 1999. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem., 274: 21056-21062.
29. Lee, A.Y., Akers, K.T., Collier, M., Li, L., Eisen, A.Z., and Seltzer, J.L. 1997. Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc. Natl. Acad. Sci. USA., 94: 4424-4429.
30. Lehti, K., Lohi, J., Valtanen, H., and Keski-Oja, J. 1998. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J., 334: 345-353.
31. Li, Y.-L., Sato, M., Kojima, N., Miura, M., and Senoo, H. 1999. Reguratory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells. Cell Struct. Funct., 24: 255-261.
32. Mercier, I., Lechaire, J.P., Desmouliere, A., Gaill, F., and Aumailley, M. 1996. Interactions of human skin fibroblasts with monomeric or fibrillar collagens induce different organization of the cytoskeleton. Exp. Cell Res., 225: 245-256.
33. Milani, S., Herbst, H., Schuppan, D., Grappone, C., Pellegrini, G., Pinzani, M., Casini, A., Calabro, A., Ciancio, G., and Stefanini, F. 1994. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am. J. Pathol., 144: 528-537.
34. Mitchell, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.F., and Hambor, J.E. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest., 97: 761-776.
35. Miura, M., Sato, M., Toyoshima, I., and Senoo, H. 1997. Extension of long cellular processes of hepatic stellate cells cultured on extracellular type I collagen gel by microtubule assembly: Observation utilizing time-lapse video-microscopy. Cell Struct. Funct., 22: 487-492.
36. Nagase, H. and Woessner, J.F. 1999. Matrix metalloproteinase. J. Biol. Chem., 274: 21491-21494.
37. Pinzani, M., Marra, F., and Carloni, V. 1998. Signal transduction in hepatic stellate cells. Liver, 18: 2-13.
38. Preaux, A.M., Mallat, A., Nhieu, J.T., D'Ortho, M.P., Hembry, R.M., and Mavier, P. 1999. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Hepatology, 30: 944-950.
39. Ravanti, L., Hakkinen, L., Larjava, H., Saarialho-Kere, U., Foschi, M., Han, J., and Kahari, V.M. 1999. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J. Biol. Chem., 274: 37292-37300.
40. Ravanti, L., Heino, J., Lopez-Otin, C., and Kahari, V.M. 1999. Induction of collagenase-13 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem., 274: 2446-2455.
41. Rojkind, M., Giambrone, M.A., and Biempica, L. 1979. Collagen types in normal and cirrhotic liver. Gastroenterology, 76: 710-719.
42. Sato, M., Kojima, N., Miura, M., Imai, K., and Senoo, H. 1998. Induction of cellular processes containing collagenase and retinoid by integrin-binding to interstitial collagen in hepatic stellate cell culture. Cell Biol. Int., 22: 115-125.
43. Sato, M., Suzuki, S., and Senoo, H. 2003. Hepatic stellate cells: Unique characteristics in cell biology and phenotype. Cell Struct. Funct., 28: 105-112.
44. Seglen, P.O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol., 13: 29-38.
45. Seltzer, J.L., Lee, A.Y., Akers, K.T., Sudbeck, B., Southon, E.A., Wayner, E.A., and Eisen, A.Z. 1994. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res., 213: 365-374.
46. Senoo, H. and Hata, R. 1994. Extracellular matrix regulates and L-ascorbic acid 2-phosphate further modulates morphology, proliferation, and collagen synthesis of perisinusoidal stellate cells. Biochem. Biophys. Res. Commun., 200: 999-1006.
47. Senoo, H., Imai, K., Matano, Y., and Sato, M. 1998. Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three-dimensional structure of the extracellular matrix. J. Gastroenterol. Hepatol., 13: 19-32.
48. Senoo, H., Imai, K., Sato, M., Kojima, N., Miura, M., and Hata, R. 1996. Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A-storing cells). Cell Biol. Int., 20: 501-512.
49. Senoo, H., Smeland, S., Malaba, L., Bjerknes, T., Stang, E., Roos, N., Berg, T., Norum, K.R., and Blomhoff, R. 1993. Transfer of retinol-binding protein from HepG2 human hepatoma cells to cocultured rat stellate cells. Proc. Natl. Acad. Sci. USA., 90: 3616-3620.
50. Seyer, J.M., Hutcheson, E.T., and Kang, A.H. 1977. Collagen polymorphism in normal and cirrhotic human liver. J. Clin. Invest., 59: 241-248.
51. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331-5338.
52. Takahara, T., Furui, K., Yata, Y., Jin, B., Zhang, L.P., Nambu, S., Sato, H., Seiki, M., and Watanabe, A. 1997. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology, 26: 1521-1529.
53. Theret, N., Lehti, K., Musso, O., and Clement, B. 1999. MMP-2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology, 30: 462-468.
54. Tomasek, J.J., Halliday, N.L., Updike, D.L., Ahern-Moore, J.S., Vu, T.K., Liu, R.W., and Howard, E.W. 1997. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem., 272: 7482-7487.
55. Vogel, W., Gish, G.D., Alves, F., and Pawson, T. 1997. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell, 1: 13-23.
56. Will, H., Atkinson, S.J., Butler, G.S., Smith, B., and Murphy, G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates auto-proteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem., 271: 17119-17123.
57. Woessner, J.F. 1994. The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci., 732: 11-21.
58. Yu, A.E., Hewitt, R.E., Connor, E.W., and Stetler-Stevenson, W.G. 1997. Matrix metalloproteinase. Novel targets for directed cancer therapy. Clin. Pharmacol., 11: 229-244.
59. Zucker, S., Drews, M., Conner, C., Foda, H.D., DeClerck, Y.A., Langley, K.E., Bahou, W.F., Docherty, A.J., and Cao, J. 1998. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase (MT1-MMP). J. Biol. Chem., 273: 1216-1222.